Ventas, Inc. (VTR) Tops Q3 FFO by 2c
Tweet
Share
E-mailGet Alerts VTR Hot Sheet
Price: $90.27 -2%
EPS Growth %: +14.3%
Financial Fact:
Medical office building services revenue: 4.32M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +14.3%
Financial Fact:
Medical office building services revenue: 4.32M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Ventas, Inc. (NYSE: VTR) reported Q3 FFO of $0.96, $0.02 better than the analyst estimate of $0.94. Revenue for the quarter came in at $641.95 million versus the consensus estimate of $629.8 million.
Sees FY2012 FFO of $3.76-3.78, versus prior guidance of $3.70-3.74 and the consensus of $2.71.
For earnings history and earnings-related data on Ventas, Inc. (VTR) click here.
Sees FY2012 FFO of $3.76-3.78, versus prior guidance of $3.70-3.74 and the consensus of $2.71.
For earnings history and earnings-related data on Ventas, Inc. (VTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
